{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:33:50Z","timestamp":1784324030447,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Patients receiving anticoagulation for atrial fibrillation (AF) are required to consult their doctor before starting Ramadan fasting to get their authorization for fasting and adapt their treatment. More often, a once-daily regimen is proposed to facilitate their intake schedule. Apixaban, a direct oral anticoagulant, prescribed twice daily with an optimal benefit\/risk ratio in numerous situations, has very limited data regarding its use during Ramadan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>The aim of this study was to evaluate the safety and the efficacy of apixaban for stroke prevention in AF patients during the month of Ramadan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An observational, multicentric study was performed in Tunisia during two consecutive years during the specific month of Ramadan. The API-RAM study included AF patients who were on apixaban and fasted at least 10\u00a0days. Efficacy was defined by the absence of ischemic events, and safety was established by classifying bleeding events using the BARC (Bleeding Academic Research Consortium) classification during the study period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 257 patients were included in our study. No ischemic events were reported during the study period. Minor bleeding events were reported in only 12 patients (4.7%), with no major bleeding event. Based on multivariate analysis, independent predictors for the bleeding risk of our population were as follows: smoking, history of hypertension, and creatinine clearance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Apixaban seems to be safe and effective for the prevention of the thromboembolic episode in AF patients during Ramadan fasting. Larger studies such as randomized clinical trials are necessary to confirm these results.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1565094","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:12:55Z","timestamp":1757909575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and effectiveness of apixaban use for stroke prevention during Ramadan fasting (the API-RAM study)"],"prefix":"10.3389","volume":"16","author":[{"given":"Aiman","family":"Ghrab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Gargouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faouzi","family":"Addad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Cheikhrouhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Jabeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Charfeddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Bahloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zied","family":"Triki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Ellouze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad","family":"Mallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faten","family":"Triki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salem","family":"Abdessalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Elalamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"B2","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/bjh.12897","article-title":"Does ramadan fasting affect the intensity of acenocoumarol-induced anticoagulant effect?","volume":"166","author":"Addad","year":"2014","journal-title":"Br. J. Haematol."},{"key":"B3","article-title":"Apixaban","volume-title":"StatPearls. Treasure Island","author":"Agrawal","year":"2024"},{"key":"B4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/heartjnl-2021-319273","article-title":"Ramadan fasting: recommendations for patients with cardiovascular disease","volume":"108","author":"Akhtar","year":"2022","journal-title":"Heart"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.19080\/ARR.2021.06.555688","article-title":"The effect of ramadan fasting on oral anticoagulant: experience of tertiary academic hospital","volume":"6","author":"AlAyoubi","year":"2021","journal-title":"Ann. Rev. and Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"13855","DOI":"10.1038\/s41598-024-64582-8","article-title":"Ramadan intermittent fasting is associated with improved anticoagulant activity among healthy people: a case\u2013control study","volume":"14","author":"Al-Ghumlas","year":"2024","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"107918","DOI":"10.1016\/j.diabres.2019.107918","article-title":"The effect of ramadan fasting on cardiovascular events and risk factors in patients with type 2 diabetes: a systematic review","volume":"159","author":"Almulhem","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/14779072.2021.1878878","article-title":"Use of NOACS in high-risk patients with atrial fibrillation in Saudi Arabia: perspectives on improving patient care","volume":"19","author":"AlShoaibi","year":"2021","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.15386\/mpr-1201","article-title":"An overview of the common methods used to measure treatment adherence","volume":"92","author":"Anghel","year":"2019","journal-title":"Med. Pharm. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11239-020-02218-0","article-title":"Patient-guided modifications of oral anticoagulant drug intake during ramadan fasting: a multicenter cross-sectional study","volume":"51","author":"Batarfi","year":"2021","journal-title":"J. Thrombosis Thrombolysis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jcph.2184","article-title":"Direct oral anticoagulants: an updated systematic review of their clinical pharmacology and clinical effectiveness and safety in patients with nonvalvular atrial fibrillation","volume":"63","author":"Bortman","year":"2023","journal-title":"J. Clin. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-015-0207-2","article-title":"Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk","volume":"14","author":"Gajos","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/00015385.2021.1882111","article-title":"Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials","volume":"77","author":"Harskamp","year":"2022","journal-title":"Acta Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00228-018-2592-4","article-title":"Effects of fasting on warfarin sensitivity index in patients undergoing cardiovascular surgery","volume":"75","author":"Katada","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3803\/EnM.2021.405","article-title":"Effects of intermittent fasting on the circulating levels and circadian rhythms of hormones","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol. Metabolism"},{"key":"B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-0038-1675798","article-title":"Smoking is associated with increased risk of major bleeding: a prospective cohort study","volume":"119","author":"Langsted","year":"2018","journal-title":"Thrombosis Haemostasis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.53555\/jaz.v44i5.3110","article-title":"Adherence to antidiabetic medication during the month of ramadan among diabetes mellitus patients in the Kingdom of Saudi Arabia","volume":"44","author":"Mirghani","year":"2023","journal-title":"J. Adv. Zoology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/clc.23558","article-title":"Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: results from the national Tunisian registry of atrial fibrillation (NATURE\u2010AF)","volume":"44","author":"Ouali","year":"2021","journal-title":"Clin. Cardiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.31083\/j.fbl2702051","article-title":"Circadian rhythms in thrombosis and atherothrombotic events","volume":"27","author":"Pe\u00f1aloza-Mart\u00ednez","year":"2022","journal-title":"Front. Bioscience-Landmark"},{"key":"B24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1037\/mot0000310","article-title":"Ramadan fasting as a goal-pursuit: why people fast, and how motives affect their experience","volume":"9","author":"Rad","year":"2023","journal-title":"Motivation Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/healthcare11020175","article-title":"Prevalence of cardio-embolic brain complications in permanent and paroxysmal atrial fibrillation patients","volume":"11","author":"Rosca","year":"2023","journal-title":"Healthcare"},{"key":"B26","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.3390\/ijms21217818","article-title":"Impact of acute and chronic stress on thrombosis in healthy individuals and cardiovascular disease patients","volume":"21","author":"Sandrini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","article-title":"Assessing bleeding risk in patients taking anticoagulants","volume":"35","author":"Shoeb","year":"2013","journal-title":"J. thrombosis thrombolysis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/jcpt.13254","article-title":"Does fasting during ramadan influence the therapeutic effect of warfarin?","volume":"46","author":"Sridharan","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1036496","DOI":"10.3389\/fnut.2022.1036496","article-title":"Religious fasting and its impacts on individual, public, and planetary health: fasting as a \u201creligious health asset\u201d for a healthier, more equitable, and sustainable society","volume":"9","author":"Trabelsi","year":"2022","journal-title":"Front. Nutr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/europace\/euu311","article-title":"Non-vitamin K antagonist oral anticoagulants: considerations on once-vs. twice-daily regimens and their potential impact on medication adherence","volume":"17","author":"Vrijens","year":"2015","journal-title":"EP Eur."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/CIRCULATIONAHA.123.065614","article-title":"Associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease","volume":"148","author":"Xu","year":"2023","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.5505\/amj.2023.70842","article-title":"Evaluation of medication adherence of individuals with chronic diseases during ramadan","volume":"23","author":"Yilmaz","year":"2023","journal-title":"Ankara Med. J."},{"key":"B33","first-page":"1177","article-title":"Oral anticoagulation therapy using acenocoumarol during the month of ramadan: a comparative study between fasting and non-fasting patients","volume":"97","author":"Zghal Mghaieth","year":"2019","journal-title":"La Tunis. Medicale"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1565094\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:12:56Z","timestamp":1757909576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1565094\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":30,"alternative-id":["10.3389\/fphar.2025.1565094"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1565094","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"1565094"}}